Irritable  ||| S:0 E:10 ||| NNP
Bowel  ||| S:10 E:16 ||| NNP
Syndrome ||| S:16 E:24 ||| NNP
:  ||| S:24 E:26 ||| :
A  ||| S:26 E:28 ||| DT
Clinical  ||| S:28 E:37 ||| NNP
Review  ||| S:37 E:44 ||| NNP
Symptoms  ||| S:44 E:53 ||| NNP
of  ||| S:53 E:56 ||| IN
irritable  ||| S:56 E:66 ||| JJ
bowel  ||| S:66 E:72 ||| JJ
syndrome  ||| S:72 E:81 ||| NN
( ||| S:81 E:82 ||| -LRB-
IBS ||| S:82 E:85 ||| NNP
)  ||| S:85 E:87 ||| -RRB-
are  ||| S:87 E:91 ||| VBP
common  ||| S:91 E:98 ||| JJ
in  ||| S:98 E:101 ||| IN
population  ||| S:101 E:112 ||| NN
studies  ||| S:112 E:120 ||| NNS
including  ||| S:120 E:130 ||| VBG
chronic  ||| S:130 E:138 ||| JJ
abdominal  ||| S:138 E:148 ||| JJ
pain  ||| S:148 E:153 ||| NN
associated  ||| S:153 E:164 ||| VBN
with  ||| S:164 E:169 ||| IN
altered  ||| S:169 E:177 ||| JJ
bowel  ||| S:177 E:183 ||| NN
habits ||| S:183 E:189 ||| NNS
.  ||| S:189 E:191 ||| .
Patients  ||| S:191 E:200 ||| NNS
often  ||| S:200 E:206 ||| RB
have  ||| S:206 E:211 ||| VBP
associated  ||| S:211 E:222 ||| VBN
gastrointestinal  ||| S:222 E:239 ||| NNS
and  ||| S:239 E:243 ||| CC
somatic  ||| S:243 E:251 ||| JJ
symptoms  ||| S:251 E:260 ||| NNS
suggesting  ||| S:260 E:271 ||| VBG
a  ||| S:271 E:273 ||| DT
possible  ||| S:273 E:282 ||| JJ
common  ||| S:282 E:289 ||| JJ
contributing  ||| S:289 E:302 ||| JJ
mechanism ||| S:302 E:311 ||| NN
,  ||| S:311 E:313 ||| ,
but  ||| S:313 E:317 ||| CC
the  ||| S:317 E:321 ||| DT
heterogeneous  ||| S:321 E:335 ||| JJ
symptom  ||| S:335 E:343 ||| NN
patterns  ||| S:343 E:352 ||| NNS
of  ||| S:352 E:355 ||| IN
individual  ||| S:355 E:366 ||| JJ
patients  ||| S:366 E:375 ||| NNS
make  ||| S:375 E:380 ||| VBP
generalizations  ||| S:380 E:396 ||| JJ
difficult ||| S:396 E:405 ||| JJ
.  ||| S:405 E:407 ||| .
The  ||| S:407 E:411 ||| DT
pathophysiology  ||| S:411 E:427 ||| NN
of  ||| S:427 E:430 ||| IN
IBS  ||| S:430 E:434 ||| NNP
is  ||| S:434 E:437 ||| VBZ
incompletely  ||| S:437 E:450 ||| VBN
understood  ||| S:450 E:461 ||| VBN
but  ||| S:461 E:465 ||| CC
includes  ||| S:465 E:474 ||| VBZ
disturbances  ||| S:474 E:487 ||| VBN
of  ||| S:487 E:490 ||| IN
the  ||| S:490 E:494 ||| DT
brain-gut  ||| S:494 E:504 ||| JJ
axis ||| S:504 E:508 ||| NN
.  ||| S:508 E:510 ||| .
Central  ||| S:510 E:518 ||| JJ
mechanisms  ||| S:518 E:529 ||| NNS
are ||| S:529 E:532 ||| VBP
:  ||| S:532 E:534 ||| :
the  ||| S:534 E:538 ||| DT
psychosocial  ||| S:538 E:551 ||| JJ
history  ||| S:551 E:559 ||| NN
and  ||| S:559 E:563 ||| CC
environment ||| S:563 E:574 ||| NN
,  ||| S:574 E:576 ||| ,
dysfunctional  ||| S:576 E:590 ||| JJ
brain  ||| S:590 E:596 ||| NN
processing  ||| S:596 E:607 ||| NN
of  ||| S:607 E:610 ||| IN
peripheral  ||| S:610 E:621 ||| JJ
signals  ||| S:621 E:629 ||| NNS
attributed  ||| S:629 E:640 ||| VBD
to  ||| S:640 E:643 ||| TO
the  ||| S:643 E:647 ||| DT
intestine  ||| S:647 E:657 ||| NN
including  ||| S:657 E:667 ||| VBG
the  ||| S:667 E:671 ||| DT
enteric  ||| S:671 E:679 ||| JJ
nervous  ||| S:679 E:687 ||| JJ
system ||| S:687 E:693 ||| NN
,  ||| S:693 E:695 ||| ,
the  ||| S:695 E:699 ||| DT
microbiome  ||| S:699 E:710 ||| NN
and  ||| S:710 E:714 ||| CC
the  ||| S:714 E:718 ||| DT
innate  ||| S:718 E:725 ||| NN
and  ||| S:725 E:729 ||| CC
adaptive  ||| S:729 E:738 ||| JJ
immune  ||| S:738 E:745 ||| JJ
system ||| S:745 E:751 ||| NN
.  ||| S:751 E:753 ||| .
As  ||| S:753 E:756 ||| IN
a  ||| S:756 E:758 ||| DT
result  ||| S:758 E:765 ||| NN
there  ||| S:765 E:771 ||| EX
is  ||| S:771 E:774 ||| VBZ
visceral  ||| S:774 E:783 ||| JJ
hypersensitivity  ||| S:783 E:800 ||| NN
and  ||| S:800 E:804 ||| CC
disturbed  ||| S:804 E:814 ||| JJ
intestinal  ||| S:814 E:825 ||| JJ
secretory  ||| S:825 E:835 ||| NN
and  ||| S:835 E:839 ||| CC
motor  ||| S:839 E:845 ||| NN
activity ||| S:845 E:853 ||| NN
.  ||| S:853 E:855 ||| .
Some  ||| S:855 E:860 ||| DT
mechanisms  ||| S:860 E:871 ||| NNS
of  ||| S:871 E:874 ||| IN
visceral  ||| S:874 E:883 ||| JJ
pain  ||| S:883 E:888 ||| NN
hypersensitivity  ||| S:888 E:905 ||| NNS
may  ||| S:905 E:909 ||| MD
overlap  ||| S:909 E:917 ||| VB
with  ||| S:917 E:922 ||| IN
other  ||| S:922 E:928 ||| JJ
pain  ||| S:928 E:933 ||| NN
syndromes  ||| S:933 E:943 ||| VBZ
including  ||| S:943 E:953 ||| VBG
fibromyalgia  ||| S:953 E:966 ||| NNS
( ||| S:966 E:967 ||| -LRB-
FMS ||| S:967 E:970 ||| NNP
) ||| S:970 E:971 ||| -RRB-
.  ||| S:971 E:973 ||| .
Central  ||| S:973 E:981 ||| NNP
Sensitization  ||| S:981 E:995 ||| NNP
( ||| S:995 E:996 ||| -LRB-
CS ||| S:996 E:998 ||| NNP
)  ||| S:998 E:1000 ||| -RRB-
would  ||| S:1000 E:1006 ||| MD
offer  ||| S:1006 E:1012 ||| VB
a  ||| S:1012 E:1014 ||| DT
way  ||| S:1014 E:1018 ||| NN
to  ||| S:1018 E:1021 ||| TO
conceptualize  ||| S:1021 E:1035 ||| VB
an  ||| S:1035 E:1038 ||| DT
integration  ||| S:1038 E:1050 ||| NN
of  ||| S:1050 E:1053 ||| IN
life  ||| S:1053 E:1058 ||| NN
experience  ||| S:1058 E:1069 ||| NN
and  ||| S:1069 E:1073 ||| CC
psychologic  ||| S:1073 E:1085 ||| JJ
response  ||| S:1085 E:1094 ||| NN
into  ||| S:1094 E:1099 ||| IN
a  ||| S:1099 E:1101 ||| DT
biopsychosocial  ||| S:1101 E:1117 ||| JJ
framework  ||| S:1117 E:1127 ||| NN
of  ||| S:1127 E:1130 ||| IN
pathophysiologic ||| S:1130 E:1146 ||| NN
,  ||| S:1146 E:1148 ||| ,
diagnostic  ||| S:1148 E:1159 ||| JJ
and  ||| S:1159 E:1163 ||| CC
treatment  ||| S:1163 E:1173 ||| NN
favored  ||| S:1173 E:1181 ||| VBN
in  ||| S:1181 E:1184 ||| IN
the  ||| S:1184 E:1188 ||| DT
approach  ||| S:1188 E:1197 ||| NN
to  ||| S:1197 E:1200 ||| TO
IBS ||| S:1200 E:1203 ||| NNP
.  ||| S:1203 E:1205 ||| .
Corticotropin-releasing  ||| S:1205 E:1229 ||| JJ
factor ||| S:1229 E:1235 ||| NN
,  ||| S:1235 E:1237 ||| ,
a  ||| S:1237 E:1239 ||| DT
principle  ||| S:1239 E:1249 ||| NN
regulator  ||| S:1249 E:1259 ||| NN
in  ||| S:1259 E:1262 ||| IN
the  ||| S:1262 E:1266 ||| DT
stress  ||| S:1266 E:1273 ||| NN
and  ||| S:1273 E:1277 ||| CC
pain  ||| S:1277 E:1282 ||| NN
response  ||| S:1282 E:1291 ||| NN
may  ||| S:1291 E:1295 ||| MD
contribute  ||| S:1295 E:1306 ||| VB
to  ||| S:1306 E:1309 ||| TO
a  ||| S:1309 E:1311 ||| DT
neuroendocrine  ||| S:1311 E:1326 ||| JJ
mechanism  ||| S:1326 E:1336 ||| NN
for  ||| S:1336 E:1340 ||| IN
the  ||| S:1340 E:1344 ||| DT
brain-gut  ||| S:1344 E:1354 ||| JJ
interaction ||| S:1354 E:1365 ||| NN
.  ||| S:1365 E:1367 ||| .
The  ||| S:1367 E:1371 ||| DT
positive  ||| S:1371 E:1380 ||| JJ
diagnostic  ||| S:1380 E:1391 ||| JJ
approach  ||| S:1391 E:1400 ||| NN
to  ||| S:1400 E:1403 ||| TO
IBS  ||| S:1403 E:1407 ||| NNP
symptoms  ||| S:1407 E:1416 ||| NNS
to  ||| S:1416 E:1419 ||| TO
avoid  ||| S:1419 E:1425 ||| VB
excess  ||| S:1425 E:1432 ||| JJ
testing  ||| S:1432 E:1440 ||| NN
and  ||| S:1440 E:1444 ||| CC
enhance  ||| S:1444 E:1452 ||| VB
the  ||| S:1452 E:1456 ||| DT
patient-provider  ||| S:1456 E:1473 ||| JJ
therapeutic  ||| S:1473 E:1485 ||| JJ
relationship  ||| S:1485 E:1498 ||| NN
requires  ||| S:1498 E:1507 ||| VBZ
the  ||| S:1507 E:1511 ||| DT
recognition  ||| S:1511 E:1523 ||| NN
of  ||| S:1523 E:1526 ||| IN
the  ||| S:1526 E:1530 ||| DT
cluster  ||| S:1530 E:1538 ||| NN
of  ||| S:1538 E:1541 ||| IN
IBS  ||| S:1541 E:1545 ||| NNP
symptoms  ||| S:1545 E:1554 ||| NNS
while  ||| S:1554 E:1560 ||| IN
identifying  ||| S:1560 E:1572 ||| VBG
alarm  ||| S:1572 E:1578 ||| NN
symptoms  ||| S:1578 E:1587 ||| NNS
requiring  ||| S:1587 E:1597 ||| VBG
specific  ||| S:1597 E:1606 ||| JJ
attention ||| S:1606 E:1615 ||| NN
.  ||| S:1615 E:1617 ||| .
The  ||| S:1617 E:1621 ||| DT
severity  ||| S:1621 E:1630 ||| NN
of  ||| S:1630 E:1633 ||| IN
the  ||| S:1633 E:1637 ||| DT
symptoms  ||| S:1637 E:1646 ||| NNS
and  ||| S:1646 E:1650 ||| CC
other  ||| S:1650 E:1656 ||| JJ
individual  ||| S:1656 E:1667 ||| JJ
psychosocial  ||| S:1667 E:1680 ||| JJ
factors  ||| S:1680 E:1688 ||| NNS
characterize  ||| S:1688 E:1701 ||| VBP
patients  ||| S:1701 E:1710 ||| NNS
who  ||| S:1710 E:1714 ||| WP
seek  ||| S:1714 E:1719 ||| VBP
medical  ||| S:1719 E:1727 ||| JJ
care ||| S:1727 E:1731 ||| NN
.  ||| S:1731 E:1733 ||| .
The  ||| S:1733 E:1737 ||| DT
presence  ||| S:1737 E:1746 ||| NN
of  ||| S:1746 E:1749 ||| IN
significant  ||| S:1749 E:1761 ||| JJ
psychosocial  ||| S:1761 E:1774 ||| JJ
comorbidities  ||| S:1774 E:1788 ||| NN
adds  ||| S:1788 E:1793 ||| VBZ
to  ||| S:1793 E:1796 ||| TO
the  ||| S:1796 E:1800 ||| DT
complexity  ||| S:1800 E:1811 ||| NN
of  ||| S:1811 E:1814 ||| IN
management  ||| S:1814 E:1825 ||| NN
which  ||| S:1825 E:1831 ||| WDT
often  ||| S:1831 E:1837 ||| RB
requires  ||| S:1837 E:1846 ||| VBZ
a  ||| S:1846 E:1848 ||| DT
multidisciplinary  ||| S:1848 E:1866 ||| JJ
approach ||| S:1866 E:1874 ||| NN
.  ||| S:1874 E:1876 ||| .
Several  ||| S:1876 E:1884 ||| JJ
treatment  ||| S:1884 E:1894 ||| NN
options  ||| S:1894 E:1902 ||| NNS
exist  ||| S:1902 E:1908 ||| VBP
but  ||| S:1908 E:1912 ||| CC
no  ||| S:1912 E:1915 ||| DT
single  ||| S:1915 E:1922 ||| JJ
method  ||| S:1922 E:1929 ||| NN
is  ||| S:1929 E:1932 ||| VBZ
effective  ||| S:1932 E:1942 ||| JJ
for  ||| S:1942 E:1946 ||| IN
all  ||| S:1946 E:1950 ||| PDT
the  ||| S:1950 E:1954 ||| DT
symptoms  ||| S:1954 E:1963 ||| NNS
of  ||| S:1963 E:1966 ||| IN
IBS ||| S:1966 E:1969 ||| NNP
.  ||| S:1969 E:1971 ||| .
The  ||| S:1971 E:1975 ||| DT
therapeutic  ||| S:1975 E:1987 ||| JJ
benefit  ||| S:1987 E:1995 ||| NN
of  ||| S:1995 E:1998 ||| IN
the  ||| S:1998 E:2002 ||| DT
well-executed  ||| S:2002 E:2016 ||| JJ
physician-patient  ||| S:2016 E:2034 ||| JJ
relationship  ||| S:2034 E:2047 ||| NN
is  ||| S:2047 E:2050 ||| VBZ
considered  ||| S:2050 E:2061 ||| VBN
essential  ||| S:2061 E:2071 ||| JJ
to  ||| S:2071 E:2074 ||| TO
success  ||| S:2074 E:2082 ||| NN
in  ||| S:2082 E:2085 ||| IN
managing  ||| S:2085 E:2094 ||| VBG
IBS  ||| S:2094 E:2098 ||| NNP
symptoms  ||| S:2098 E:2107 ||| NNS
over  ||| S:2107 E:2112 ||| IN
the  ||| S:2112 E:2116 ||| DT
long  ||| S:2116 E:2121 ||| JJ
term ||| S:2121 E:2125 ||| NN
.  ||| S:2125 E:2127 ||| .
